Emergent BioSolutions Inc. Development Agreements

Modification No. 30, effective September 30, 2021, to the Award/Contract, effective June 15, 2012 (the BARDA ADM Contract), from the BioMedical Advance Research and Development... (Filed With SEC on November 5, 2021)

Award/Contract (the BARDA AV7909 Contract), effective September 30, 2016, from the BioMedical Advanced Research and Development Authority to Emergent Product Development... (Filed With SEC on November 5, 2021)

Modification No. 7, effective May 24, 2021, to Order for Supplies and Services Between Emergent Manufacturing Operations Baltimore LLC and the BioMedical Advance Research and... (Filed With SEC on July 30, 2021)

Order for Supplies and Services Between Emergent Manufacturing Operations Baltimore LLC and the BioMedical Advance Research and Development Authority, dated (Filed With SEC on July 30, 2021)

Modification No. 27, effective May 6, 2021, to the Award/Contract, effective June 15, 2012 (the BARDA ADM Contract), from the BioMedical Advance Research and Development Authority... (Filed With SEC on July 30, 2021)

Modification No. 3, effective, April 1, 2021, to the Award/Contract, effective August 30, 2019 (ACAM2000 Contract), from the Assistant Secretary, U.S. Department of Health and... (Filed With SEC on July 30, 2021)

Modification No. 7, effective December 2, 2020, to the Award/Contract, effective September 30, 2016, from the BioMedical Advanced Research and Development Authority to Emergent... (Filed With SEC on July 30, 2021)

Modification No. 4, effective January 29, 2021, to Order for Supplies and Services Between Emergent Manufacturing Operations Baltimore LLC and the BioMedical Advance Research and... (Filed With SEC on April 30, 2021)

Order for Supplies and Services Between Emergent Manufacturing Operations Baltimore LLC and the BioMedical Advance Research and Development Authority, dated August 6, 2020, under... (Filed With SEC on November 6, 2020)

Modification No. 1, effective August 24, 2020, to task order #75A50120F33007, between Emergent Manufacturing Operations Baltimore LLC and the BioMedical Advance Research and... (Filed With SEC on November 6, 2020)

Modification No. 21, effective June 12, 2020, to the Award/Contract, effective June 15, 2012 (the BARDA ADM Contract), from the BioMedical Advance Research and Development... (Filed With SEC on November 6, 2020)

Modification No. 6, effective July 13, 2020, to the Award/Contract, effective September 30, 2016, from the BioMedical Advanced Research and Development Authority to Emergent... (Filed With SEC on November 6, 2020)

Modification No. 1, effective, May 28, 2020 to the Award/Contract, effective August 30, 2019 (ACAM2000 Contract), from the Assistant Secretary, U.S. Department of Health and Human... (Filed With SEC on July 31, 2020)

Order for Supplies and Services Between Emergent Manufacturing Operations Baltimore LLC and the BioMedical Advance Research and Development Authority, dated May 24, 2020, under... (Filed With SEC on July 31, 2020)

Award/Contract, effective June 15, 2012 (BARDA ADM Contract), from the BioMedical Advance Research and Development Authority to Emergent Manufacturing Operations Baltimore LLC (Filed With SEC on July 31, 2020)

Modification #No. 4, effective March 3, 2020, to the Award/Contract, effective September 30, 2016, from the BioMedical Advanced Research and Development Authority to Emergent... (Filed With SEC on May 1, 2020)

Award/Contract, effective August 30, 2019 (ACAM 2000 Contract), from the Assistant Secretary, U.S. Department of Health and Human Services (ASPR/OPM) to Emergent Product... (Filed With SEC on February 25, 2020)

Award/Contract (the BARDA AV7909 Contract), effective September 30, 2016, from the BioMedical Advanced Research and Development Authority to Emergent Product Development... (Filed With SEC on February 25, 2020)

Notice of Award Letter, dated August 30, 2019, from the Department of Health and Human Services to Emergent Product Development Gaithersburg, Inc. awarding Contract 75A50119C00052... (Filed With SEC on November 7, 2019)

Modification #3, effective July 30, 2019, to the Award/Contract, effective September 30, 2016, from the BioMedical Advanced Research and Development Authority to Emergent Product... (Filed With SEC on November 7, 2019)

Modification No. 2, effective August 29, 2018 to the Award/Contract, effective September 30, 2016, from the BioMedical Advanced Research and Development Authority to Emergent... (Filed With SEC on November 2, 2018)

SEGRO (WINNERSH) LIMITED (1) EMERGENT PRODUCT DEVELOPMENT UK LIMITED (2) DEED OF SURRENDER relating to Units 545 Winnersh Triangle, Wokingham, Berkshire (Filed With SEC on August 5, 2011)